Canada Life
OCUL icon

Canada Life’s Ocular Therapeutix OCUL Stock Holding History

Canada Life’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$182K Buy
18,621
+6,645
+55% +$60.2K ﹤0.01% 1603
2026
Q1 		$102K Hold
11,976
– – ﹤0.01% 1689
2025
Q4 		$145K Sell
11,976
-19,938
-62% -$242K ﹤0.01% 1670
2025
Q3 		$400K Buy
31,914
+4,729
+17% +$56.5K ﹤0.01% 1634
2025
Q2 		$253K Buy
27,185
+15,209
+127% +$119K ﹤0.01% 1689
2025
Q1 		$88K Sell
11,976
-18,251
-60% -$140K ﹤0.01% 1796
2024
Q4 		$258K Buy
30,227
+18,251
+152% +$178K ﹤0.01% 1729
2024
Q3 		$104K Hold
11,976
– – ﹤0.01% 1865
2024
Q2 		$82K Buy
+11,976
New +$73.9K ﹤0.01% 1913
2022
Q2 		– Sell
-4,020
Closed -$21K – 2452
2022
Q1 		$21K Hold
4,020
– – ﹤0.01% 2340
2021
Q4 		$28K Hold
4,020
– – ﹤0.01% 2310
2021
Q3 		$40K Hold
4,020
– – ﹤0.01% 2289
2021
Q2 		$57K Hold
4,020
– – ﹤0.01% 2232
2021
Q1 		$65K Hold
4,020
– – ﹤0.01% 2213
2020
Q4 		$83K Buy
+4,020
New +$59.7K ﹤0.01% 2154
2016
Q4 		– Sell
-6,146
Closed -$42K – 2539
2016
Q3 		$42K Hold
6,146
– – ﹤0.01% 2364
2016
Q2 		$30K Sell
6,146
-10,000
-62% -$99.1K ﹤0.01% 2424
2016
Q1 		$155K Hold
16,146
– – ﹤0.01% 1471
2015
Q4 		$151K Buy
+16,146
New +$174K ﹤0.01% 1462

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Life's OCUL Position: Q2 2026 in Review

Canada Life increased its Ocular Therapeutix (OCUL) stake by 55% in Q2 2026, buying an estimated $60.2K and bringing the position to 18,621 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Canada Life first reported a position in OCUL in Q4 2015 and has held it in 19 quarters since. The position peaked at $400K in Q3 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Canada Life held 18,621 shares of Ocular Therapeutix worth $182K as of Q2 2026.
  • Canada Life bought 6,645 Ocular Therapeutix shares in Q2 2026, an estimated $60.2K.
  • Ocular Therapeutix made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1603 holding.
  • Canada Life first reported a position in Ocular Therapeutix in Q4 2015 and has held it in 19 quarters since.
  • Canada Life's Ocular Therapeutix position peaked at $400K in Q3 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.